🇺🇸 vigamox in United States

1,526 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Chronic Kidney Disease — 208 reports (13.63%)
  2. Off Label Use — 184 reports (12.06%)
  3. Eye Pain — 183 reports (11.99%)
  4. Vision Blurred — 169 reports (11.07%)
  5. Visual Acuity Reduced — 152 reports (9.96%)
  6. Renal Failure — 149 reports (9.76%)
  7. Acute Kidney Injury — 132 reports (8.65%)
  8. Toxic Anterior Segment Syndrome — 120 reports (7.86%)
  9. Endophthalmitis — 117 reports (7.67%)
  10. Drug Ineffective — 112 reports (7.34%)

Source database →

Other Other approved in United States

Frequently asked questions

Is vigamox approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for vigamox in United States?

Ophthalmology Consultants, Ltd. is the originator. The local marketing authorisation holder may differ — check the official source linked above.